| Lev Iofis, MD | |
|
10333 El Camino Real, Atascadero, CA 93423-7001 | |
| (805) 468-2000 | |
| (805) 466-6011 |
| Full Name | Lev Iofis |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Forensic Psychiatry |
| Location | 10333 El Camino Real, Atascadero, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124070396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084F0202X | Psychiatry & Neurology - Forensic Psychiatry | A64506 (California) | Primary |
| Entity Name | Department Of State Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124078704 PECOS PAC ID: 9638174238 Enrollment ID: O20081031000305 |
News Archive
Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.
What began as a chat between husband and wife has evolved into an intriguing scientific discovery. The results, published in May in BMJ (formerly British Medical Journal) Open, show a "highly significant" correlation between periodic solar storms and incidences of rheumatoid arthritis (RA) and giant cell arteritis (GCA), two potentially debilitating autoimmune diseases.
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new paper in the journal Genome Biology, a team of scientists describes a new and uniquely advantageous way to detect them.
St. Jude Medical, Inc. today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Genesis™ spinal cord stimulation system for the management of chronic pain.
A potentially powerful new approach to treating two lethal metastatic cancers - triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer - has been discovered by researchers at Mayo Clinic in Florida.
› Verified 5 days ago
| Entity Name | Martin Luther King Jr Community Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356899777 PECOS PAC ID: 8628359502 Enrollment ID: O20170109001311 |
News Archive
Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.
What began as a chat between husband and wife has evolved into an intriguing scientific discovery. The results, published in May in BMJ (formerly British Medical Journal) Open, show a "highly significant" correlation between periodic solar storms and incidences of rheumatoid arthritis (RA) and giant cell arteritis (GCA), two potentially debilitating autoimmune diseases.
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new paper in the journal Genome Biology, a team of scientists describes a new and uniquely advantageous way to detect them.
St. Jude Medical, Inc. today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Genesis™ spinal cord stimulation system for the management of chronic pain.
A potentially powerful new approach to treating two lethal metastatic cancers - triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer - has been discovered by researchers at Mayo Clinic in Florida.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lev Iofis, MD 1600 9th Street, Room 205 Mailstop 2-3, Sacramento, CA 95814-6414 Ph: (916) 654-2431 | Lev Iofis, MD 10333 El Camino Real, Atascadero, CA 93423-7001 Ph: (805) 468-2000 |
News Archive
Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.
What began as a chat between husband and wife has evolved into an intriguing scientific discovery. The results, published in May in BMJ (formerly British Medical Journal) Open, show a "highly significant" correlation between periodic solar storms and incidences of rheumatoid arthritis (RA) and giant cell arteritis (GCA), two potentially debilitating autoimmune diseases.
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new paper in the journal Genome Biology, a team of scientists describes a new and uniquely advantageous way to detect them.
St. Jude Medical, Inc. today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Genesis™ spinal cord stimulation system for the management of chronic pain.
A potentially powerful new approach to treating two lethal metastatic cancers - triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer - has been discovered by researchers at Mayo Clinic in Florida.
› Verified 5 days ago
Dr. Marc H. Reiner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10333 El Camino Real, Atascadero, CA 93422 Phone: 805-468-2000 | |
Hadley Charles Osran, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10333 El Camino Real, Atascadero, CA 93423 Phone: 805-468-2000 Fax: 805-466-6011 | |
Clarice P Chan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10333 El Camino Real, Atascadero, CA 93422 Phone: 805-468-2000 | |
Dr. Jonathan R Funk, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10333 El Camino Real, Atascadero, CA 93422 Phone: 805-468-2188 | |
Dr. James Rafael Pitts, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10333 El Camino Real, Atascadero, CA 93422 Phone: 805-468-2055 | |
Elouisa V Dizon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10333 El Camino Real, Atascadero, CA 93423 Phone: 805-468-2000 Fax: 805-466-6011 | |
Michael Henry Lisiak, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10333 El Camino Real, Atascadero, CA 93423 Phone: 805-468-2000 Fax: 805-466-6011 |